Sign in
Active, not recruitingNo phase

Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants

Key facts

Who runs it
Montefiore Medical Center
Where
Greenville, United StatesSee the site
Trial code
Status
Active, not recruiting
People taking part
80 people, planned
Started
17 Dec 2021
Ended
Aug 2026
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Peer mentor
  • Standard of care
Record updated
20 April 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • currently incarcerated or recently released from a U.S. jail or prison (6 months)
  • Chronic HCV with documented detectable viral load
  • 18 years old
  • Fluent in English or Spanish
  • Resident of the Upstate area of South Carolina

Who cannot take part

  • Unable to sign informed consent
  • Life expectancy of less than 1 year
  • Plans to relocate from the Upstate area of South Carolina in the next 6 months

Where in United States

  • Prisma Health-UpstateGreenville, United States

About the trial

What the trial wants to find out

The overarching goal of this study is to develop a peer-based care coordination intervention for individuals with Hepatitis C Virus (HCV) who were recently released from correctional settings to promote linkage to and retention in HCV care. The investigators will assess the existing barriers and facilitators of HCV treatment initiation, HCV treatment completion, and sustained virologic response among individuals recently released from a U.S. jail or prisons in a randomized control trial. This study will assess the feasibility and process measures of a peer-enhanced HCV care coordination intervention among recently incarcerated individuals.

The 2 groups in the trial

  • Peer-enhanced interventionTreatment being tested

    Those randomized to the peer-enhanced intervention group will be contacted by a peer mentor within 72 hours of enrollment to discuss the early release period, readiness for HCV treatment, and identify ancillary needs. Individuals randomized to this arm will be provided a study cell phone.

    Treatment: Peer mentor

  • Standard of carePlacebo, for comparison

    If randomized to the standard of care intervention, the participant will only receive passive referral to HCV-care.

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
HCV-ACCELERATE Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants
Publications
Record updated
20 April 2026